OPIANT PHARMACEUTICALS, INC. reports

Company location: Santa Monica, CA
Fiscal year end: 31 December

OPIANT PHARMACEUTICALS, INC. has filed 578 SEC EDGAR filings since 11 Jan 2007

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 26-50 of 545 matching filings.

Per page

25

Current page

2

4

FORM 4

Filing date: 03 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

25-NSE File 001-38193

25-NSE filing

Filing date: 02 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 02 Mar 2023
Reporting date: 02 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 01 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 27 Feb 2023
Reporting date: 23 Feb 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-38193

DEFA14A

Filing date: 22 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DFAN14A File 001-38193

DFAN14A

Filing date: 16 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-90404

SC 13G/A

Filing date: 15 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-38193

DEFA14A

Filing date: 07 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 07 Feb 2023
Reporting date: 02 Feb 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DFAN14A File 001-38193

DFAN14A

Filing date: 06 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 31 Jan 2023
Reporting date: 27 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 31 Jan 2023
Reporting date: 27 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 31 Jan 2023
Reporting date: 27 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 31 Jan 2023
Reporting date: 27 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 31 Jan 2023
Reporting date: 27 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 09 Jan 2023
Reporting date: 09 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 09 Jan 2023
Reporting date: 09 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 09 Jan 2023
Reporting date: 09 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 09 Jan 2023
Reporting date: 09 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 09 Jan 2023
Reporting date: 04 Jan 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2023
Reporting date: 05 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2023
Reporting date: 05 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2023
Reporting date: 05 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .